Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.240
-0.060 (-4.62%)
Mar 26, 2026, 4:00 PM EDT - Market closed

Pulmonx Revenue

In the year 2025, Pulmonx had annual revenue of $90.50M with 8.01% growth. Pulmonx had revenue of $22.60M in the quarter ending December 31, 2025, a decrease of -4.91%.

Revenue (ttm)
$90.50M
Revenue Growth
+8.01%
P/S Ratio
0.58
Revenue / Employee
$305,733
Employees
296
Market Cap
52.37M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202590.50M6.71M8.01%
Dec 31, 202483.79M15.11M22.01%
Dec 31, 202368.68M15.01M27.98%
Dec 31, 202253.66M5.25M10.84%
Dec 31, 202148.42M15.68M47.91%
Dec 31, 202032.73M138.00K0.42%
Dec 31, 201932.60M12.59M62.94%
Dec 31, 201820.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Accuray436.97M
Outset Medical119.48M
LENSAR59.14M
Cytosorbents36.98M
electroCore32.03M
Sensus Healthcare27.48M
Spectral AI19.65M
Elutia12.29M
Revenue Rankings